cells. These stromal compartments are critical in driving PDA biology [3] . individual cell [4] and provides a powerful tool to understand the cellular heterogeneity of PDA.
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We applied scRNA-seq to investigate gene expression changes of cancer cells and stromal KIC, KPC and KPfC mice were generated as previously described [5] [6] [7] . Mice were sacrificed 1 1 6 when they were moribund: 60 days old for the KIC (n = 3, late PDA) and KPfC (n = 1) or 6 1 1 7 months old for the KPC (n = 1). The 2 KIC mice were sacrificed at 40 days old (early PDA) and 1 1 8 "normal pancreas" mice (n = 2) were sacrificed at 60 days old. In experiments using more than 1 1 9 one mouse, tissues were pooled prior to enzymatic digestion. The KPfC mouse had a pure 1 2 0 C57BL/6 genetic background and all others had a mixed background (C57BL/6 with FVB). Ultrasound imaging was carried out under general anesthesia with isoflurane. Mice were Animals were strictly followed. Tissues were either fixed in 10% formalin for 1 2 4 immunohistochemistry or enzymatically digested for single-cell analysis. [16] as well as Pi16, which has been shown to be expressed in fibroblast populations in various tissue types [17] , in addition to Ly6a and Ly6c1. FB3 showed distinct expression of mesothelial 3 4 5 markers such as Lrrn4, Gpm6a, Nkain4, Lgals7, and Msln [18] in addition to other genes previously shown to be expressed in fibroblasts such as Cav1, Cdh11, . Ccl2, Ccl7, Cxcl12, and Pdgfra were expressed in FB1 and FB2 in the normal pancreas and early KIC tumors, and showed greater expression in FB1 of late KIC (Fig. 5C ). In contrast, the 3 5 6 myofibroblast markers Acta2 and Tagln were expressed by a portion of FB3. These data support the presence of previously described, mutually exclusive, inflammatory (FB1) and II-associated genes (Fig. 5C ). GO analysis suggested that FB1 was involved in an acute phase 3 6 0 response and inflammatory response, FB2 was more associated with physiological functions of 1 2 and had complement activation functions (Fig. 5D ). Furthermore, we analyzed genes that 3 6 3 increased in FB1 and FB3 during PDA progression, and found that FB1 showed a progressive 3 6 4 increase in the expression of genes associated with inflammatory response and chemotaxis 3 6 5
( Fig. 5E and Supplementary Fig. 4B ) while FB3 genes displayed increased function on 3 6 6 translation during disease progression, possibly due to enhanced antigen processing activity.
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These data suggest that FB1 is an inflammatory population and the inflammatory feature 3 6 8 increases during PDA progression, while FB3 consists of the well-studied myofibroblast 3 6 9 population, and displays an enrichment for class 2 MHC genes. We also found that some genes essentially exclusive to FB3 in the normal and early KIC 3 7 2 pancreas became expressed in FB1 and FB3 populations in late KIC, marking these genes as
potential global fibroblast markers in advanced PDA. One such gene was Cdh11 (Fig. 5C ). We
validated these data by immunohistochemistry. We found in late KIC tumors, stromal staining
for αSMA and PDGFRα were nearly mutually exclusive, whereas CDH11 showed uniform
staining across all morphologically discernable fibroblasts (Fig. 5F ). Taken together, these data
provide the first in vivo description of all CAF populations during PDA progression. mesenchymal cancer cell population in the late KIC tumor displayed a marked increase in total
UMI count with a median count of 18,334 and range of 4433-50,061 (Fig. 6C ). The epithelial
cancer cells in the late KIC also displayed an increased UMI, albeit to a far lesser degree than 3 9 2 the mesenchymal cancer cell population (median: 10,368, range: 4940-30,440 ). We reasoned that the increased transcriptional activity may be associated with increased and mesenchymal cancer cells while Myc was expressed mainly in the mesenchymal cancer 4 0 0 cell population (Fig. 6C, Supplementary Fig. 6 ). In addition, several genes encoding high- progression and lays the foundation for the development of novel therapeutic approaches. contribution to metastasis has been more controversial [34, 35] . Mesenchymal cancer cells recruit regulatory complexes to acetylated histones at enhancer sites, resulting in increased macrophages expanded during tumor progression and contributed to PDA growth and survival.
6
progresses, an inflammatory feature is substantially increased, and this accompanies an 4 9 9
increase of an important M2 macrophage marker, ARG1 ( Fig associated with worse survival in human PDA sections. These data prompted a paradigm shift
whereby certain CAFs may function to constrain, rather than promote, PDA. Moreover, until
recently, the molecular heterogeneity of CAFs in PDA has not been well-appreciated. The were produced in vitro when PSCs were indirectly co-cultured with mouse PDA organoids There are no additional unpublished data from this study. 
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